Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shahrul Mt-Isa

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Statistics in Medicine|April 17, 2019
A Bayesian approach for individual-level drug benefit-risk assessmentKan Li, Sheng Luo, Sammy Yuan, et al.
Biometrical Journal. Biometrische Zeitschrift|January 30, 2015
A Bayesian approach to probabilistic sensitivity analysis in structured benefit-risk assessmentEd Waddingham, Shahrul Mt-Isa, Richard Nixon, et al.
Pharmacoepidemiology and Drug Safety|November 18, 2006
Lack of effect of influenza immunisation on anticoagulant control in patients on long-term warfarinPeter MacCallum, Manisha Madhani, Shahrul Mt-Isa, et al.
Expert Review of Vaccines|October 21, 2021
Matching-adjusted indirect comparison of pneumococcal vaccines V114 and PCV20Shahrul Mt-Isa, Lauren A Abderhalden, Luwy Musey, et al.
Postgraduate Medical Journal|November 26, 2010
Republished paper: Where errors occur in the preparation and administration of intravenous medicines: a systematic review and Bayesian analysisSarah E McDowell, Shahrul Mt-Isa, Deborah Ashby, et al.
Quality & Safety in Health Care|January 13, 2010
Where errors occur in the preparation and administration of intravenous medicines: a systematic review and Bayesian analysisSarah E McDowell, Shahrul Mt-Isa, Deborah Ashby, et al.
Plos One|February 27, 2020
Bayesian credible subgroup identification for treatment effectiveness in time-to-event dataDuy Ngo, Richard Baumgartner, Shahrul Mt-Isa, et al.
Critical Reviews in Oncology/Hematology|January 23, 2017
Challenges and methodology in the incorporation of biomarkers in cancer clinical trialsCharlotte S Wilhelm-Benartzi, Shahrul Mt-Isa, Francesca Fiorentino, et al.
Pharmaceutical Statistics|May 19, 2015
Structured Benefit-risk assessment: a review of key publications and initiatives on frameworks and methodologiesShahrul Mt-Isa, Mario Ouwens, Veronique Robert, et al.
Expert Review of Vaccines|September 30, 2025
Indirect comparison of the immunogenicity of 15-valent and 20-valent pneumococcal conjugate vaccines in children using a 2+1 scheduleShahrul Mt-Isa, Justin R Chumbley, Matthew S Kelly, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Statistics in Medicine|April 17, 2019
A Bayesian approach for individual-level drug benefit-risk assessmentKan Li, Sheng Luo, Sammy Yuan, et al.
Biometrical Journal. Biometrische Zeitschrift|January 30, 2015
A Bayesian approach to probabilistic sensitivity analysis in structured benefit-risk assessmentEd Waddingham, Shahrul Mt-Isa, Richard Nixon, et al.
Pharmacoepidemiology and Drug Safety|November 18, 2006
Lack of effect of influenza immunisation on anticoagulant control in patients on long-term warfarinPeter MacCallum, Manisha Madhani, Shahrul Mt-Isa, et al.
Expert Review of Vaccines|October 21, 2021
Matching-adjusted indirect comparison of pneumococcal vaccines V114 and PCV20Shahrul Mt-Isa, Lauren A Abderhalden, Luwy Musey, et al.
Postgraduate Medical Journal|November 26, 2010
Republished paper: Where errors occur in the preparation and administration of intravenous medicines: a systematic review and Bayesian analysisSarah E McDowell, Shahrul Mt-Isa, Deborah Ashby, et al.
Quality & Safety in Health Care|January 13, 2010
Where errors occur in the preparation and administration of intravenous medicines: a systematic review and Bayesian analysisSarah E McDowell, Shahrul Mt-Isa, Deborah Ashby, et al.
Plos One|February 27, 2020
Bayesian credible subgroup identification for treatment effectiveness in time-to-event dataDuy Ngo, Richard Baumgartner, Shahrul Mt-Isa, et al.
Critical Reviews in Oncology/Hematology|January 23, 2017
Challenges and methodology in the incorporation of biomarkers in cancer clinical trialsCharlotte S Wilhelm-Benartzi, Shahrul Mt-Isa, Francesca Fiorentino, et al.
Pharmaceutical Statistics|May 19, 2015
Structured Benefit-risk assessment: a review of key publications and initiatives on frameworks and methodologiesShahrul Mt-Isa, Mario Ouwens, Veronique Robert, et al.
Expert Review of Vaccines|September 30, 2025
Indirect comparison of the immunogenicity of 15-valent and 20-valent pneumococcal conjugate vaccines in children using a 2+1 scheduleShahrul Mt-Isa, Justin R Chumbley, Matthew S Kelly, et al.
Pageof 5